YahooAugust 17, 2026 at 4:28 PM NY18 days ago

ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles

On August 6, ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 results capping a year of double-digit growth. Quarterly revenue rose 9% to $1.5 billion, and non-GAAP earnings per share jumped 16% to $2.95. For the full fiscal year, which closed June 30, 2026, revenue grew 10%, and free cash flow topped $1.6 billion. The company also […]

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

RMDResmed Inc228.35− 0.37%

Companies in This Story

Related Stories